Literature DB >> 15700791

[Crataegus from the analytical viewpoint. Official contents of hawthorn drugs].

Frank Petereit1, Adolf Nahrstedt.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15700791     DOI： 10.1002/pauz.200400100

Source DB:  PubMed          Journal:  Pharm Unserer Zeit        ISSN： 0048-3664


× No keyword cloud information.
  2 in total

1.  Hydroxycinnamic Acid Derivatives Obtained from a Commercial Crataegus Extract and from Authentic Crataegus spp.

Authors:  Ulrich Kuczkowiak; Frank Petereit; Adolf Nahrstedt
Journal:  Sci Pharm       Date:  2014-08-21

2.  Crataegus Extract WS®1442 Stimulates Cardiomyogenesis and Angiogenesis From Stem Cells: A Possible New Pharmacology for Hawthorn?

Authors:  Jonas Halver; Kristin Wenzel; Jandirk Sendker; Carmen Carrillo García; Clemens A J Erdelmeier; Erik Willems; Mark Mercola; Nico Symma; Stephanie Könemann; Egon Koch; Andreas Hensel; Dennis Schade
Journal:  Front Pharmacol       Date:  2019-11-27       Impact factor: 5.810
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.